For example, downregulation of SIRT1 expression by EX527 enhanced cell sensitivity to bortezomib in multiple melanoma [42], while SIRT1 inhibition by tenovin-6 in combination with tyrosine kinase inhibitor imatinib targeted leukemia stem cells, leading to reduction of their growth [43]. The gene discussed is SIRT1; the disease is leukemia.